Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma

Table 5 Adverse events attributed to both treatment arms

Adverse events (CTCAE grades 1-3)	TACE alone	TACE + sorafenib	P value
Hand foot skin reaction	0	2	0.554
Diarrhea	0	1
Hypertension (mild)	0	1
Abdominal pain (mild)	6	1
Nausea, vomiting	3	0
Elevated liver enzymes (< 2 times of normal limits)	1	2

TACE: Transarterial chemoembolization; CTCAE: Common terminology criteria for adverse events.